These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31578881)

  • 1. Circulating tumor DNA
    Sun X; Li H; Sun M; Yuan Y; Sun L
    Future Oncol; 2019 Oct; 15(30):3513-3525. PubMed ID: 31578881
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
    Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
    Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang Z; Chen P; Xie H; Cao P
    Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
    Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.
    Hu H; Zhou C; Li B; Chen Y; Dai J; Mao Y; Huang T; Yu H; Chen M; Zhao J; Duan S
    Pathol Res Pract; 2018 Oct; 214(10):1572-1578. PubMed ID: 30082160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene promoter methylation and cancer: An umbrella review.
    Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
    Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis.
    Li M; Wang C; Yu B; Zhang X; Shi F; Liu X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31196964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
    Sun G; Meng J; Duan H; Zhang D; Tang Y
    Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management.
    Wang B; Wang M; Lin Y; Zhao J; Gu H; Li X
    Clin Chem Lab Med; 2024 Oct; 62(11):2111-2127. PubMed ID: 38443752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang J; Yuan Y; Gao S; Zhao X; Li H
    Biomark Med; 2021 Feb; 15(3):219-239. PubMed ID: 33470842
    [No Abstract]   [Full Text] [Related]  

  • 15. MethHC 2.0: information repository of DNA methylation and gene expression in human cancer.
    Huang HY; Li J; Tang Y; Huang YX; Chen YG; Xie YY; Zhou ZY; Chen XY; Ding SY; Luo MF; Jin CN; Zhao LS; Xu JT; Zhou Y; Lin YC; Hong HC; Zuo HL; Hu SY; Xu PY; Li X; Huang HD
    Nucleic Acids Res; 2021 Jan; 49(D1):D1268-D1275. PubMed ID: 33270889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Significance and Diagnostic Value of DLEC1 Hypermethylation in Lung Cancer: A Meta-analysis.
    Li X; Mao W; Guo D; Xu H
    J Nippon Med Sch; 2019; 86(2):62-69. PubMed ID: 31130567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
    Cheng J; Tang Q; Cao X; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.